Cargando…

A catalytically silent FAAH-1 variant drives anandamide transport in neurons

The endocannabinoid anandamide is removed from the synaptic space by a selective transport system, expressed in neurons and astrocytes, which remains molecularly uncharacterized. Here we describe a partly cytosolic variant of the intracellular anandamide-degrading enzyme, fatty acid amide hydrolase-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Jin, Bottegoni, Giovanni, Sasso, Oscar, Bertorelli, Rosalia, Rocchia, Walter, Masetti, Matteo, Guijarro, Ana, Lodola, Alessio, Armirotti, Andrea, Garau, Gianpiero, Bandiera, Tiziano, Reggiani, Angelo, Mor, Marco, Cavalli, Andrea, Piomelli, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245783/ https://www.ncbi.nlm.nih.gov/pubmed/22101642 http://dx.doi.org/10.1038/nn.2986

Ejemplares similares

Role of FAAH-Like Anandamide Transporter in Anandamide Inactivation
por: Leung, KwanNok, et al.
Publicado: (2013)

Ketoconazole Inhibits the Cellular Uptake of Anandamide via Inhibition of FAAH at Pharmacologically Relevant Concentrations
por: Björklund, Emmelie, et al.
Publicado: (2014)

A Swath Label-Free Proteomics insight into the Faah(−/−) Mouse Liver
por: Hamid, Zeeshan, et al.
Publicado: (2018)

Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity
por: Habib, Abdella M., et al.
Publicado: (2019)

A Catalytic Mechanism for Cysteine N-Terminal Nucleophile Hydrolases, as Revealed by Free Energy Simulations
por: Lodola, Alessio, et al.
Publicado: (2012)

Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease
por: Capurro, Valeria, et al.
Publicado: (2013)

Systematic Exploitation of Multiple Receptor Conformations for Virtual Ligand Screening
por: Bottegoni, Giovanni, et al.
Publicado: (2011)

The ligand binding mechanism to purine nucleoside phosphorylase elucidated via molecular dynamics and machine learning
por: Decherchi, Sergio, et al.
Publicado: (2015)

Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition
por: Cippitelli, Andrea, et al.
Publicado: (2011)

Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent N-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral Administration
por: Di Fruscia, Paolo, et al.
Publicado: (2021)

FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway
por: Ravi, Janani, et al.
Publicado: (2014)

A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
por: Deutsch, Dale G.
Publicado: (2016)

EHMTI-0141. URB937 as a potential therapeutic option for migraine: evaluation in animal model of migraine
por: Greco, R, et al.
Publicado: (2014)

Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism
por: Starowicz, Katarzyna, et al.
Publicado: (2013)

Targeting the Endocannabinoid System for Neuroprotection: A (19)F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA
por: Zhuang, Jianqin, et al.
Publicado: (2013)

Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity
por: Realini, Natalia, et al.
Publicado: (2013)

Different roles for the acyl chain and the amine leaving group in the substrate selectivity of N-Acylethanolamine acid amidase
por: Ghidini, Andrea, et al.
Publicado: (2021)

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
por: Leweke, F M, et al.
Publicado: (2012)

Rapid evaluation of 25 key sphingolipids and phosphosphingolipids in human plasma by LC-MS/MS
por: Basit, Abdul, et al.
Publicado: (2015)

Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment
por: Wei, Don, et al.
Publicado: (2016)

Mapping Cholesterol Interaction Sites on Serotonin Transporter through Coarse-Grained Molecular Dynamics
por: Ferraro, Mariarosaria, et al.
Publicado: (2016)

FAAH inhibitors in the limelight, but regrettably
por: Mallet, Christophe, et al.
Publicado: (2016)

Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity
por: Lopes, João P, et al.
Publicado: (2013)

Ion mobility mass spectrometry enhances low-abundance species detection in untargeted lipidomics
por: Basit, Abdul, et al.
Publicado: (2016)

Advanced mycelium materials as potential self-growing biomedical scaffolds
por: Antinori, Maria Elena, et al.
Publicado: (2021)

FAAH selectively influences placebo effects
por: Peciña, M., et al.
Publicado: (2013)

The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

New insights into the mechanisms of anandamide-induced airway dilation placing its degradation enzyme, FAAH center stage. Commentary on: Simon A, von Einem T, Seidinger A, Matthey M, Bindila L, Wenzel D (2022) The endocannabinoid anandamide is an airway relaxant in health and disease. Nat Commun 13:6941
por: Pfitzer, Gabriele
Publicado: (2023)

A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity
por: Conzelmann, Annette, et al.
Publicado: (2012)

Insights into Ligand–Protein Binding from Local Mechanical Response
por: Patel, Jagdish Suresh, et al.
Publicado: (2011)

Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury
por: Genovese, Tiziana, et al.
Publicado: (2022)

Author Correction: The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta
por: Liessi, Nara, et al.
Publicado: (2020)

Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders
por: Savardi, Annalisa, et al.
Publicado: (2020)

Vaccenic acid suppresses intestinal inflammation by increasing anandamide and related N-acylethanolamines in the JCR:LA-cp rat
por: Jacome-Sosa, Miriam, et al.
Publicado: (2016)

Possible Anandamide and Palmitoylethanolamide involvement in human stroke
por: Naccarato, Marcello, et al.
Publicado: (2010)

Inactivation of Anandamide Signaling: A Continuing Debate
por: Khairy, Hesham, et al.
Publicado: (2010)

Anandamide inhibits breast tumor-induced angiogenesis
por: Picardi, P, et al.
Publicado: (2014)

Alterations in the Anandamide Metabolism in the Development of Neuropathic Pain
por: Malek, Natalia, et al.
Publicado: (2014)

The endocannabinoid anandamide is an airway relaxant in health and disease
por: Simon, Annika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j62f5agkmtulcjf9e58rohubcc